Latest Filana Therapeutics News & Updates

See the latest news and media coverage for Filana Therapeutics. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Filana Therapeutics

Clinical-stage biotechnology company developing treatments for central nervous system disorders

filanatx.com
Headquarters
Austin, United States
Company type
Public company
Number of employees
14–50
Industry
Pharmaceuticals

Last updated

Latest news about Filana Therapeutics

In short: Filana Therapeutics advanced simufilam toward a Phase 2a epilepsy study after FDA lifted its clinical hold.

Company announcements

Filana Therapeutics

Filana Therapeutics reports Q1 2026 financial results

The company reported a net loss of $10.3 million and provided updates on its TSC program's regulatory progress with the FDA.

Unlock all announcements with a

Media coverage

Finanznachrichten

Filana Therapeutics, Inc.: Filana Therapeutics Reports Q1 2026 Financial Results and Business Update

AUSTIN, Texas, May 07, 2026 (GLOBE NEWSWIRE) -- Filana Therapeutics, Inc. (NASDAQ: FLNA, "Filana Therapeutics", the "Company"), a biotechnology company currently focused on developing therapies...

Unlock all articles with a

Never miss news about Filana Therapeutics

Track Filana Therapeutics and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.